Pulse Biosciences, Inc. Costs and Expenses
Pulse Biosciences, Inc. (PLSE) reported Costs and Expenses of $25.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-06
- Pulse Biosciences, Inc. costs and expenses for the quarter ending 2026-06-30 was $25.71M, a 26.79% increase year-over-year.
- Pulse Biosciences, Inc. costs and expenses for the quarter ending 2026-03-31 was $19.55M, a 8.35% increase year-over-year.
- Pulse Biosciences, Inc. costs and expenses for the quarter ending 2025-12-31 was $18.52M, a 8.61% decline year-over-year.
- Pulse Biosciences, Inc. costs and expenses for the quarter ending 2025-09-30 was $20.45M, a 49.78% increase year-over-year.
- Pulse Biosciences, Inc. costs and expenses for fiscal 2025 was $77.29M, a 37.39% increase from fiscal 2024.
- Pulse Biosciences, Inc. costs and expenses for fiscal 2024 was $56.26M, a 29.11% increase from fiscal 2023.
- Pulse Biosciences, Inc. costs and expenses for fiscal 2023 was $43.57M, a 25.84% decline from fiscal 2022.
- Pulse Biosciences, Inc. costs and expenses for fiscal 2022 was $58.76M, a 8.81% decline from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.71M 10-Q · filed 2026-08-06 | $45.26M 10-Q · filed 2026-08-06 | $63.77M derived: sum of 3 quarters · filed 2026-08-06 | $84.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $19.55M 10-Q · filed 2026-05-14 | $38.07M derived: sum of 2 quarters · filed 2026-05-14 | $58.52M derived: sum of 3 quarters · filed 2026-05-14 | $78.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $18.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $38.97M derived: sum of 2 quarters · filed 2026-02-19 | $59.24M derived: sum of 3 quarters · filed 2026-08-06 | $77.29M 10-K · filed 2026-02-19 |
| 2025-09-30 | $20.45M 10-Q · filed 2025-11-05 | $40.73M derived: sum of 2 quarters · filed 2026-08-06 | $58.77M 10-Q · filed 2025-11-05 | $79.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $20.27M 10-Q · filed 2026-08-06 | $38.32M 10-Q · filed 2026-08-06 | $58.58M derived: sum of 3 quarters · filed 2026-08-06 | $72.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $18.04M 10-Q · filed 2026-05-14 | $38.30M derived: sum of 2 quarters · filed 2026-05-14 | $51.96M derived: sum of 3 quarters · filed 2026-05-14 | $63.69M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $20.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $33.92M derived: sum of 2 quarters · filed 2026-02-19 | $45.64M derived: sum of 3 quarters · filed 2026-02-19 | $56.26M 10-K · filed 2026-02-19 |
| 2024-09-30 | $13.65M 10-Q · filed 2025-11-05 | $25.38M derived: sum of 2 quarters · filed 2025-11-05 | $36.00M 10-Q · filed 2025-11-05 | $48.53M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $11.73M 10-Q · filed 2025-08-12 | $22.34M 10-Q · filed 2025-08-12 | $34.87M derived: sum of 3 quarters · filed 2025-08-12 | $46.13M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $10.62M 10-Q · filed 2025-05-08 | $23.15M derived: sum of 2 quarters · filed 2025-05-08 | $34.40M derived: sum of 3 quarters · filed 2025-05-08 | $44.63M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $12.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $23.79M derived: sum of 2 quarters · filed 2025-03-31 | $34.01M derived: sum of 3 quarters · filed 2025-03-31 | $43.57M 10-K · filed 2025-03-31 |
| 2023-09-30 | $11.25M 10-Q · filed 2024-10-30 | $21.48M derived: sum of 2 quarters · filed 2024-10-30 | $31.04M 10-Q · filed 2024-10-30 | $39.78M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $10.23M 10-Q · filed 2024-08-19 | $19.79M 10-Q · filed 2024-08-19 | $28.52M derived: sum of 3 quarters · filed 2024-08-19 | $46.55M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $9.56M 10-Q · filed 2024-05-07 | $18.30M derived: sum of 2 quarters · filed 2024-05-07 | $36.32M derived: sum of 3 quarters · filed 2024-05-07 | $50.60M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $26.76M derived: sum of 2 quarters · filed 2024-03-28 | $41.04M derived: sum of 3 quarters · filed 2024-03-28 | $58.76M 10-K · filed 2024-03-28 |
| 2022-09-30 | $18.02M 10-Q · filed 2023-11-13 | $32.30M derived: sum of 2 quarters · filed 2023-11-13 | $50.02M 10-Q · filed 2023-11-13 | $66.28M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $14.28M 10-Q · filed 2023-08-10 | $32.00M 10-Q · filed 2023-08-10 | $48.25M derived: sum of 3 quarters · filed 2023-08-10 | $63.10M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $17.72M 10-Q · filed 2023-05-11 | $33.97M derived: sum of 2 quarters · filed 2023-05-11 | $48.82M derived: sum of 3 quarters · filed 2023-05-11 | $63.62M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $16.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $31.10M derived: sum of 2 quarters · filed 2023-03-31 | $45.91M derived: sum of 3 quarters · filed 2023-03-31 | $64.43M 10-K · filed 2023-03-31 |
| 2021-09-30 | $14.85M 10-Q · filed 2022-11-10 | $29.65M derived: sum of 2 quarters · filed 2022-11-10 | $48.18M 10-Q · filed 2022-11-10 | $61.93M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-06-30 | $14.81M 10-Q · filed 2022-08-10 | $33.33M 10-Q · filed 2022-08-10 | $47.09M derived: sum of 3 quarters · filed 2023-03-31 | $59.99M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-03-31 | $18.52M 10-Q · filed 2022-05-11 | $32.28M derived: sum of 2 quarters · filed 2023-03-31 | $45.19M derived: sum of 3 quarters · filed 2023-03-31 | |
| 2020-12-31 | $13.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $26.66M derived: sum of 2 quarters · filed 2023-03-31 | $49.97M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $12.90M 10-Q · filed 2021-11-15 | $36.21M 10-Q · filed 2021-11-15 | ||
| 2019-12-31 | $47.95M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |